News
BCTXL
1.000
+7.53%
0.070
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/18 11:30
BriaCell reports 9 of 25 Phase 2 metastatic breast cancer patients alive more than 18-47 months post-enrollment
Reuters · 03/17 14:32
BriaCell Therapeutics Q2 FY2026 net loss widens 15% to USD 7.3 million
Reuters · 03/10 21:09
BriaCell to present four posters at the AACR Annual Meeting
Reuters · 03/10 11:53
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
Barchart · 03/10 06:30
BriaPro to Buy BriaCell’s Exclusive Soluble CD80 License in Asset Deal
Reuters · 02/20 21:01
BriaPro to Buy BriaCell’s Exclusive Soluble CD80 License in Asset Deal
Reuters · 02/18 22:30
BRIACELL THERAPEUTICS CORP: AS PART OF TRANSACTION, BRIACELL WILL MAKE AVAILABLE TO BRIAPRO UP TO $3 MLN TO FUND RESEARCH AND DEVELOPMENT EFFORT
Reuters · 02/18 22:30
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
Barchart · 02/18 16:30
BRIACELL RECEIVES POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD (DSMB) FOR PHASE 3 STUDY IN METASTATIC BREAST CANCER
Reuters · 02/17 12:30
BriaCell Advances Phase 3 Bria-IMT Study After Positive Safety Review
Reuters · 02/17 12:30
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Barchart · 02/17 06:30
BriaCell Therapeutics Corp. Announces Date for Upcoming Annual General and Special Meeting of Shareholders
Reuters · 02/12 21:01
BriaCell Therapeutics Reports Tumor Regression in Phase 2 Study of Bria-IMT for Metastatic Breast Cancer
Reuters · 01/28 12:30
BRIACELL PATIENTS’ IMAGES SHOW REGRESSION AND RESOLUTION OF METASTASIZED TUMORS AND IMMUNE ACTIVATION
Reuters · 01/28 12:30
BriaCell Reports Extended Survival in Phase 2 Metastatic Breast Cancer Trial
Reuters · 01/27 17:05
BriaCell Highlights Extended >18-47 MONTHS SURVIVAL IN PHASE 2 METASTATIC BREAST CANCER PATIENTS
Reuters · 01/27 12:30
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Barchart · 01/27 06:30
More
Webull provides a variety of real-time BCTXL stock news. You can receive the latest news about Briacell Therapeutics Corp through multiple platforms. This information may help you make smarter investment decisions.